Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

Download results of this page


Browse by:

Content type

Project (452)
Result in Brief (1416)
Report Summary (474)

Country

Albania (3)
Algeria (1)
Argentina (5)
Australia (8)
Austria (83)
Bangladesh (2)
Belarus (2)
Belgium (131)
Benin (3)
Bolivia (2)
Bosnia and Herzegovina (1)
Botswana (1)
Brazil (4)
Bulgaria (10)
Burkina Faso (6)
Cambodia (1)
Cameroon (3)
Canada (7)
Chile (4)
China (5)
Colombia (2)
Croatia (8)
Cyprus (5)
Czech Republic (27)
Côte d’Ivoire (1)
Democratic Republic of the Congo (4)
Denmark (71)
Ecuador (2)
Egypt (5)
Estonia (15)
Ethiopia (1)
Finland (63)
Former Yugoslav Republic of Macedonia (1)
France (283)
Gabon (1)
Georgia (1)
Germany (365)
Ghana (13)
Greece (29)
Guinea-Bissau (1)
Hong Kong (2)
Hungary (34)
Iceland (5)
India (18)
Indonesia (1)
Ireland (52)
Israel (78)
Italy (207)
Japan (2)
Kenya (7)
Latvia (7)
Lebanon (1)
Lithuania (13)
Luxembourg (4)
Malawi (5)
Malaysia (2)
Mali (6)
Mexico (1)
Montenegro (1)
Morocco (3)
Mozambique (2)
Nepal (3)
Netherlands (198)
New Zealand (1)
Nigeria (4)
Norway (35)
Paraguay (1)
Peru (3)
Philippines (1)
Poland (31)
Portugal (40)
Romania (16)
Russia (8)
Senegal (4)
Serbia (1)
Singapore (1)
Slovakia (10)
Slovenia (13)
South Africa (11)
South Korea (3)
Spain (178)
Sudan (3)
Sweden (155)
Switzerland (138)
Taiwan (1)
Tanzania (8)
Thailand (2)
The Gambia (1)
Togo (2)
Tunisia (6)
Turkey (13)
Uganda (9)
United Arab Emirates (1)
United Kingdom (375)
United States (34)
Uruguay (3)
Venezuela (3)
Vietnam (4)
Zambia (1)
Zimbabwe (2)

Advanced search

Search projects and results

Results 1 - 10 of 2342
Results/page:
12 3 4 5 6 7 8 9 10 > >| 
Enabling NAnomedicine TRANSlation
[PROJECT] ENATRANS - Enabling NAnomedicine TRANSlation
ID: 646113
Start date: 2015-01-01, End date: 2017-12-31
ENATRANS’ main objective is to network and support SMEs in translation of nanomedicine in Europe by providing a one-stop-shop service to interact and share information, experience and advice with up-to-date information and interactive tools, but also enabling personal...
Programme: H2020-EU.2.3.2.2.
Record Number: 194413
Last updated on: 2017-06-23
World class Science and Innovation with Neutrons in Europe 2020 – SINE2020
ID: 654000
Start date: 2015-10-01, End date: 2019-09-30
Today’s society is being transformed by new materials and processes. Analytical techniques underpin their development and neutrons, with their unique properties, play a pivotal role in a multi-disciplinary, knowledge-based approach. Industry and the neutron research...
Programme: H2020-EU.1.4.1.1.
Record Number: 198195
Last updated on: 2017-06-23
Type 1 Diabetes Self-Management and Carbohydrate Counting: A Computer Vision based Approach
ID: 286408
Start date: 2011-09-01, End date: 2015-08-31
Patients with diabetes must be taught how to achieve glycaemic control by monitoring their glucose levels properly. They are medicated with either exogenous insulin or other drugs and encouraged to improve their diet and physical activity. Although studies have shown that pla...
Programme: FP7-PEOPLE
Record Number: 100244
Last updated on: 2017-04-03
Periodic Report Summary 3 - RATHER (Rational Therapy for Breast Cancer: Individualized Treatment for Difficult-to-Treat Breast Cancer Subtypes)
Cancer genotyping has identified a number of correlations between mutations in specific genes and responses to targeted anti-cancer drugs, with many mutations occurring in kinases or downstream signaling components. The RATHER consortium are...
Programme: FP7-HEALTH
Record Number: 175821
Last updated on: 2016-01-19
Rational Therapy for Breast Cancer: Individualized Treatment for Difficult-to-Treat Breast Cancer Subtypes
ID: 258967
Start date: 2011-01-01, End date: 2018-06-30
Cancer genotyping has identified a number of correlations between mutations in specific genes and responses to targeted anti-cancer drugs, with many mutations occurring in kinases or downstream signaling components. While there are several ongoing large-scale genome re-sequen...
Programme: FP7-HEALTH
Record Number: 97660
Last updated on: 2017-07-16
Estrategias contra cánceres de mama difíciles
La labor de genotipificación del cáncer ha permitido identificar varias correlaciones entre las mutaciones en genes específicos y las respuestas a fármacos oncológicos dirigidos. Estas mutaciones específicas del cáncer pueden conducir al diseño de tratamientos más precisos y personalizados.
Programme: FP7-HEALTH
Record Number: 90777
Last updated on: 2013-03-29
Available languages: DE, EN, ES, FR, IT, PL
Schwer behandelbare Formen des Brustkrebses
Die Genotypisierung von Tumorzellen ergab mehrere Korrelationen zwischen Mutationen in bestimmten Genen und Antworten auf gezielte Krebstherapien. Auf Basis dieser krebsspezifischen Mutationen könnte nun die Entwicklung einer zielgerichteteren und personalisierteren Therapie befördert werden.
Programme: FP7-HEALTH
Record Number: 90777
Last updated on: 2013-03-29
Available languages: DE, EN, ES, FR, IT, PL
Tackling difficult-to-treat breast cancers
Cancer genotyping has identified a number of correlations between mutations in specific genes and responses to targeted anti-cancer drugs. These cancer-specific mutations may lead to the design of more targeted and personalised treatment.
Programme: FP7-HEALTH
Record Number: 90777
Last updated on: 2013-03-29
Available languages: DE, EN, ES, FR, IT, PL
La lutte contre les cancers du sein difficiles à traiter
Le génotypage du cancer a identifié un nombre de corrélations entre les mutations dans les gènes spécifiques et les réponses aux médicaments anti-cancéreux ciblés. Ces mutations spécifiques au cancer pourraient entraîner la conception d'un traitement personnalisé plus ciblé.
Programme: FP7-HEALTH
Record Number: 90777
Last updated on: 2013-03-29
Available languages: DE, EN, ES, FR, IT, PL
Affrontare i tumori al seno difficili da trattare
La genotipizzazione del cancro ha identificato numerose correlazioni tra le mutazioni dei geni specifici e le risposte ai medicinali anticancro mirati. Queste mutazioni oncologiche specifiche possono portare allo studio di trattamenti più mirati e personalizzati.
Programme: FP7-HEALTH
Record Number: 90777
Last updated on: 2013-03-29
Available languages: DE, EN, ES, FR, IT, PL
12 3 4 5 6 7 8 9 10 > >| 
List retrieved on: 2017-07-24
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top